Early growth response 3 (EGR3), as a novel zinc finger transcription factor, is a newly discovered tumor suppressor gene, which can inhibit the growth of hepatocellular carcinoma, gastric cancer, and other cancer cells by up-regulation of Fas ligand [77]. Here, EGR3 is linked to neoplasm.